Episode Details

New Study: Diabetes Drugs Show Promise in Preventing Addictions

A large-scale study of over 600,000 veterans with diabetes reveals that GLP-one drugs like Ozempic and Mounjaro could help prevent addictions. These drugs, known for managing diabetes and weight loss, were found to reduce risks of substance use disorders by 18% for alcohol, 14% for cannabis, 20% for cocaine and nicotine, and 25% for opioids. The study also showed significant benefits for those already battling addiction, including reduced emergency room visits, hospital stays, overdose risks, and death risks. However, the studys focus on older male veterans with diabetes and its observational nature limit its conclusions, and further randomized trials are needed to confirm these drugs potential in treating addiction.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/6d8dd862d55e961e